Predicting COVID‐19 infection risk in lymphoma by immune monitoring
dc.contributor.author | Wijaya, R | en_US |
dc.contributor.author | Campbell, N | en_US |
dc.contributor.author | Johnson, M | en_US |
dc.contributor.author | Stuart, B | en_US |
dc.contributor.author | Kelly, A | en_US |
dc.contributor.author | Tipler, N | en_US |
dc.contributor.author | Coleman, A | en_US |
dc.contributor.author | Turaj, A | en_US |
dc.contributor.author | Menne, T | en_US |
dc.contributor.author | Ahearne, M | en_US |
dc.contributor.author | Willimott, V | en_US |
dc.contributor.author | Al‐Naeeb, AB | en_US |
dc.contributor.author | Fox, CP | en_US |
dc.contributor.author | Collins, GP | en_US |
dc.contributor.author | O'Callaghan, A | en_US |
dc.contributor.author | Davies, AJ | en_US |
dc.contributor.author | Goldblatt, D | en_US |
dc.contributor.author | Lim, SH | en_US |
dc.date.accessioned | 2023-06-22T09:48:10Z | |
dc.date.issued | 2023-06 | en_US |
dc.identifier.issn | 0278-0232 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/89124 | |
dc.format.extent | 606 - 607 | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Hematological Oncology | en_US |
dc.title | Predicting COVID‐19 infection risk in lymphoma by immune monitoring | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1002/hon.3164_456 | en_US |
pubs.issue | S2 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 41 | en_US |